Related Experiment Videos
Different H-2 subregions influence immunization against retrovirus and immunosuppression
R P Morrison1, P L Earl, J Nishio
1Laboratory of Persistent Viral Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana 59840.
Nature
|October 22, 1987
Summary
Friend Murine Leukemia Virus (FV) causes immunosuppression, similar to HIV. Genetic factors influence FV susceptibility and protection, with T-cell priming being key for vaccine efficacy.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Friend Murine Leukemia Virus (FV) complex induces an immunosuppressive retroviral disease in mice.
- FV infection in susceptible mouse strains mimics human immunodeficiency virus (HIV) infection, characterized by T-cell immunosuppression and antibody responses that fail to clear the virus.
- Previous studies indicated that mouse Major Histocompatibility Complex (MHC) genes influence both FV-induced immunosuppression and protection via vaccinia-FV envelope recombinant virus immunization.
Purpose of the Study:
- To investigate the specific roles of different subregions of the H-2 complex in susceptibility to FV-induced immunosuppression and in protection conferred by vaccinia-FV immunization.
- To elucidate the mechanism of protection induced by vaccinia-FV immunization, focusing on the role of T-cell priming, neutralizing antibodies, and cytotoxic T lymphocytes (CTLs).
Main Methods:
- Utilizing mouse models with defined H-2 haplotypes to assess susceptibility to FV-induced immunosuppression.
- Evaluating the efficacy of immunization with a vaccinia-FV envelope recombinant virus in conferring protection against FV challenge.
- Analyzing immune responses, including antibody production and CTL activity, following immunization and subsequent virus challenge.
Main Results:
- Different H-2 subregions govern susceptibility to immunosuppression (H-2D) and protection by recombinant vaccinia virus immunization (H-2K or I-A).
- Susceptibility to FV-induced immunosuppression does not prevent effective protection through vaccinia-FV immunization.
- The protective mechanism appears to rely on the priming of immune T cells, rather than the initial induction of neutralizing antibodies or CTLs.
Conclusions:
- Host genetic factors, specifically MHC genes, play distinct roles in FV pathogenesis and vaccine-induced protection.
- Vaccinia-FV immunization can protect against FV, with protection mediated by T-cell priming, suggesting potential strategies for HIV vaccine development.
- Understanding host genetic influences is crucial for developing effective vaccines against retroviral infections like FV and potentially HIV.